Velge Bertrand's Form 4 filing
LifeMD, Inc. (LFMD) ยท filed Dec 7, 2021
- Accession no.
- 0001362118-21-000051
- Filed
- Dec 7, 2021, 3:52 PM ET
- Trade date
- Sep 30, 2019-Dec 3, 2021
- Filing delay
- 799 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 9 derivative transactions. Open-market purchases total $543.1K. It was filed 799 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Velge BertrandCIK 0001758339 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2020 | Common Stock | PPurchaseAcquired | +294,118 | $0.17 | +$50,000.06 | 511,509 | Direct | |
| Aug 5, 2020 | Common Stock | AGrant or awardAcquired | +173,234 | $0.00 | $0 | 684,743 | Direct | |
| Sep 22, 2020 | Common Stock | PPurchaseAcquired | +96,923 | $0.65F3 | +$62,999.95 | 781,666 | Direct | |
| Dec 3, 2021 | Common Stock | PPurchaseAcquired | +110,000 | $3.91F2 | +$430,100 | 891,666 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2019 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Dec 31, 2019 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Mar 31, 2020 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Jun 30, 2020 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Sep 22, 2020 | Common Stock | AGrant or awardAcquired | +100,000 | $0.00 | $0 | 100,000 | Direct | |
| Sep 30, 2020 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Dec 31, 2020 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Mar 31, 2021 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct | |
| Jun 30, 2020 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 2,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
Referenced by the price of 1 transaction in Table I.
- F3
Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt.
Referenced by the price of 1 transaction in Table I.